Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.270
-0.060 (-1.39%)
Feb 11, 2025, 4:00 PM EST - Market closed
ZYBT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Feb '25 Feb 11, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 201 | - | - | - |
| Enterprise Value | 211 | - | - | - |
| Debt / Equity Ratio | 0.25 | 0.26 | 0.18 | 0.09 |
| Debt / EBITDA Ratio | 1.62 | 1.30 | 0.76 | 0.44 |
| Debt / FCF Ratio | 1.86 | 2.20 | - | 2.35 |
| Asset Turnover | 0.38 | 0.42 | 0.54 | - |
| Inventory Turnover | 1.42 | 1.62 | 2.17 | - |
| Quick Ratio | 0.73 | 0.77 | 0.95 | 0.86 |
| Current Ratio | 1.38 | 1.37 | 1.41 | 1.31 |
| Return on Equity (ROE) | 7.15% | 10.78% | 16.50% | - |
| Return on Assets (ROA) | 3.82% | 5.52% | 8.59% | - |
| Return on Capital (ROIC) | 4.48% | 6.61% | 10.75% | - |
| Return on Capital Employed (ROCE) | 8.73% | 12.87% | 18.04% | 16.41% |
| Payout Ratio | 183.91% | 125.42% | 45.84% | 28.36% |
Source: S&P Capital IQ. Standard template.
Financial Sources.